user

Serious Adverse Events and Hepatic Decompensation in Hepatitis C Virus infected Patients on Sofosbuvir- and/or Simeprevir-based Therapies

被引：0
|
作者：
Perumalswami, Ponni [1 ]
Bichoupan, Kian [1 ]
Yalamanchili, Rachana [1 ]
Harty, Alyson [1 ]
Gardenier, Donald [1 ]
Ng, Michel [1 ]
Motamed, David B. [1 ]
Khaitova, Viktoriya [1 ]
Bach, Nancy [1 ]
Chang, Charissa Y. [1 ]
Im, Gene Y. [1 ]
Leong, Jennifer [1 ]
Ku, Lawrence [1 ]
Schiano, Thomas D. [1 ]
Dieterich, Douglas [1 ]
Branch, Andrea D. [1 ]
机构：
[1] Mt Sinai Med Ctr, New York, NY 10029 USA
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1016
引用
收藏
页码：694A / 695A
页数：2
相关论文
共 50 条
  • [21] Hepatic Decompensation in Antiretroviral-Treated Patients Co-Infected With HIV and Hepatitis C Virus Compared With Hepatitis C Virus-Monoinfected Patients A Cohort Study
    Lo Re, Vincent, III
    Kallan, Michael J.
    Tate, Janet P.
    Localio, A. Russell
    Lim, Joseph K.
    Goetz, Matthew Bidwell
    Klein, Marina B.
    Rimland, David
    Rodriguez-Barradas, Maria C.
    Butt, Adeel A.
    Gibert, Cynthia L.
    Brown, Sheldon T.
    Park, Lesley
    Dubrow, Robert
    Reddy, K. Rajender
    Kostman, Jay R.
    Strom, Brian L.
    Justice, Amy C.
    [J]. ANNALS OF INTERNAL MEDICINE, 2014, 160 (06) : 369 - +
  • [22] Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen
    Bourgeois, Stefan
    Horsmans, Yves
    Nevens, Frederik
    van Vlierberghe, Hans
    Moreno, Christophe
    Beumont, Maria
    Vijgen, Leen
    van Eygen, Veerle
    Luo, Donghan
    Hillewaert, Vera
    Van Remoortere, Pieter
    van de Logt, Jolanda
    Ouwerkerk-Mahadevan, Sivi
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (12)
  • [23] All-Cause Mortality and Progression Risks to Hepatic Decompensation and Hepatocellular Carcinoma in Patients Infected With Hepatitis C Virus
    Xu, Fujie
    Moorman, Anne C.
    Tong, Xin
    Gordon, Stuart C.
    Rupp, Loralee B.
    Lu, Mei
    Teshale, Eyasu H.
    Spradling, Philip R.
    Boscarino, Joseph A.
    Trinacty, Connie M.
    Schmidt, Mark A.
    Holmberg, Scott D.
    [J]. CLINICAL INFECTIOUS DISEASES, 2016, 62 (03) : 289 - 297
  • [24] PHARMACOKINETIC INTERACTIONS BETWEEN SIMEPREVIR AND LEDIPASVIR IN TREATMENT-NAIVE HEPATITIS C VIRUS GENOTYPE 1-INFECTED PATIENTS WITHOUT CIRRHOSIS TREATED WITH A SIMEPREVIR/SOFOSBUVIR/LEDIPASVIR REGIMEN
    Bourgeois, S.
    Horsmans, Y.
    Nevens, F.
    van Vlierberghe, H.
    Moreno, C.
    Beumont, M.
    van de Logt, J.
    Vijgen, L.
    van Eygen, V.
    Luo, D.
    Hillewaert, V.
    Van Remoortere, P.
    Ouwerkerk-Mahadevan, S.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S820 - S820
  • [25] Evaluation of Simeprevir-Based Triple Therapy Using Pegylated-Interferon-α and Ribavirin in Patients With Hepatitis C Virus Genotype-1b Infection
    Nakatani, Toshiya
    Fujinaga, Yukihisa
    Tomooka, Fumimasa
    Ishida, Koji
    Kaya, Daisuke
    Takagi, Hirotetsu
    Saikawa, Soichiro
    Nagamatsu, Shinsaku
    Shimozato, Naotaka
    Matsuo, Hideki
    Kikuchi, Eiryo
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S884 - S884
  • [26] Sofosbuvir-Based Therapies for Patients with Hepatitis C Virus Infection: Real-World Experience in China
    Hu, Chengguang
    Yuan, Guosheng
    Liu, Junwei
    Huang, Huaping
    Ren, Yanyu
    Li, Yinping
    Chen, Xuefu
    Li, Wei
    Wu, Tao
    Deng, Hong
    Peng, Yanzhong
    Zhang, Yong-Yuan
    Zhou, Yuanping
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 2018
  • [27] Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
    Liu, Chen-Hua
    Su, Tung-Hung
    Liu, Chun-Jen
    Hong, Chun-Ming
    Yang, Hung-Chih
    Tseng, Tai-Chung
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (09) : 1620 - 1625
  • [28] Hepatitis E Virus Does Not Contribute to Hepatic Decompensation Among Patients With Advanced Chronic Hepatitis C
    Samala, Niharika
    Wright, Elizabeth C.
    Buckler, A. Gretchen
    Vargas, Vanessa
    Shetty, Kirti
    Reddy, K. Rajender
    Lucey, Michael R.
    Alter, Harvey J.
    Hoofnagle, Jay H.
    Ghany, Marc G.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (06) : 896 - 902
  • [29] Impact of Daclatasvir-Sofosbuvir Combination Treatment on Medical Events and Costs in Patients Infected with Genotype 3 Hepatitis C Virus
    Gorsh, Boris
    Sill, Bruce E.
    Hede, Shalini
    Thibault, Catherine St-Laurent
    Moorjaney, Divya
    Ganz, Michael
    Kalsekar, Anupama
    Yuan, Yong
    [J]. HEPATOLOGY, 2015, 62 : 920A - 921A
  • [30] Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosis
    Merli, Marco
    Galli, Laura
    Marinaro, Letizia
    Ariaudo, Alessandra
    Messina, Emanuela
    Uberti-Foppa, Caterina
    Castagna, Antonella
    D'Avolio, Antonio
    Lazzarin, Adriano
    Bonora, Stefano
    Hasson, Hamid
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (03) : 812 - 815
12345